Showing results (111-120 of 181) with videos related to

Sort By:
Pageof 19
Somatic Cell and Molecular Genetics|November 1, 1994
Minimum essential region of CCG1/TAFII250 required for complementing the temperature-sensitive cell cycle mutants, tsBN462 and ts13 cells, of hamster BHK21 cellsE Noguchi, T Sekiguchi, Y Nohiro, et al.
Journal of the Neurological Sciences|June 1, 1995
Vocal cord abductor paralysis (VCAP) in Parkinson's disease: difference from VCAP in multiple system atrophyE Isozaki, T Shimizu, K Takamoto, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 1, 1996
D-type cyclin expression is decreased and p21 and p27 CDK inhibitor expression is increased when tsBN462 CCG1/TAFII250 mutant cells arrest in G1 at the restrictive temperatureT Sekiguchi, E Noguchi, T Hayashida, et al.
Acta Oto-Laryngologica|November 1, 1989
Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Cellular uptake and functional correlatesT Hayashida, H Hiel, D Dulon, et al.
Kidney International|July 2, 1998
Interleukin (IL)-1 and IL-4 synergistically stimulate NF-IL6 activity and IL-6 production in human mesangial cellsY Nakazato, T Hayashida, Y Kanno, et al.
Hearing Research|January 1, 1992
Cellular and subcellular localization of tritiated gentamicin in the guinea pig cochlea following combined treatment with ethacrynic acidH Hiel, A Schamel, J P Erre, et al.
Acta Oto-Laryngologica. Supplementum|January 1, 1995
Neuro-otological and neuropathological findings in two cases with Machado-Joseph diseaseT Murofushi, M Mizuno, T Hayashida, et al.
The American Journal of Physiology|March 1, 1996
Interleukin-4 modulates collagen synthesis by human mesangial cells in a type-specific mannerY Nakazato, H Okada, S Tajima, et al.
Cell and Tissue Research|April 1, 1987
Uptake and retention of 3H-estradiol by gonadotrophs and lactotrophs in the pituitary glands of the guinea pig, hamster and gerbilH Nogami, D C Herbert, W B Winborn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2009
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancerH Jinno, M Sakata, T Hayashida, et al.
Pageof 19